The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Double-Blind, Placebo-Controlled Study of Dialectical Behavior Therapy Plus Olanzapine for Borderline Personality Disorder
Abstract
OBJECTIVE: The aim of this study was to determine the efficacy and safety of dialectical behavior therapy plus olanzapine compared with dialectical behavior therapy plus placebo in patients with borderline personality disorder. METHOD: Sixty patients with borderline personality disorder were included in a 12-week, double-blind, placebo-controlled study. All patients received dialectical behavior therapy and were randomly assigned to receive either olanzapine or placebo following a 1-month baseline period. RESULTS: Seventy percent of the patients completed the 4-month trial. Combined treatment showed an overall improvement in most symptoms studied in both groups. Olanzapine was associated with a statistically significant improvement over placebo in depression, anxiety, and impulsivity/aggressive behavior. The mean dose of olanzapine was 8.83 mg/day. CONCLUSIONS: A combined psychotherapeutic plus pharmacological approach appears to lower dropout rates and constitutes an effective treatment for borderline personality disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the pharmacotherapy review (Stoffers 2010) included three trials testing psychotherapy plus drug against psychotherapy plus placebo (Simpson 2004;Soler 2005;Linehan 2008).”
From Psychological therapies for people with borderline personality disorder. (2012) · cites this paper as Soler 2005
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Oldham, J. M. (2005) · Focus · doi:10.1176/foc.3.3.396 · Cited by 429
Dialectical behavior therapy: Current status, recent developments, and future directions
Robins, C. J., & Chapman, A. L. (2004) · Journal of Personality Disorders · doi:10.1521/pedi.18.1.73.32771 · Cited by 275
Olanzapine Treatment of Female Borderline Personality Disorder Patients
Zanarini, M. C., & Frankenburg, F. R. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1103 · Cited by 251
Olanzapine Versus Placebo in the Treatment of Borderline Personality Disorder
Bogenschutz, M. P., & Nurnberg, H. G. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0118 · Cited by 168
Research works printed but not linked: 1
- Barrachina J, Soler J, Campins MJ, Tejero A, Pascual JC, Alvarez E, Zanarini MC, Perez Sola V: Validation of a Spanish version of the Diagnostic Interview for Borderlines—Revised (DIB-R). Actas Esp Psiquiatr 2004; 32:293–298
Cited by
Sorted by citations
Psychological therapies for people with borderline personality disorder.
Stoffers-Winterling, J. M., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652.pub2 · Cited by 895
Borderline personality disorder
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61422-5 · Cited by 895
Efficacy of the third wave of behavioral therapies: A systematic review and meta- analysis
Öst, L.-G. (2008) · Behaviour Research and Therapy · doi:10.1016/j.brat.2007.12.005 · Cited by 727
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490
“1999 [62–68]; 2000 [69–73]; 2001 [74–90]; 2002 [37,91–106]; 2003 [107–132]; 2004 [133–157]; 2005 [158–191]; 2006 [46,192– 218]; 2007 [219–254]; 2008 [45,49,255–286]; 2009 [287–317]; 2010 [43,318–338]; 2011 [50,339–359]”
Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials
Lieb, K., Vӧllm, B., Rücker, G., Timmer, A., & Stoffers-Winterling, J. M. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.062984 · Cited by 403
Pharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
Soler, J., Pascual, J. C., Tiana, T., Cebrià, A., Barrachina, J., Campins, M. J., Gich, I., Alvarez, E., & Pérez, V. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.01.013 · Cited by 267
Self-citationDialectical Behavior Therapy for Adolescents: Theory, Treatment Adaptations, and Empirical Outcomes
MacPherson, H. A., Cheavens, J. S., & Fristad, M. A. (2012) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-012-0126-7 · Cited by 202
Chen, E. Y., Matthews, L., Allen, C., Kuo, J. R., & Linehan, M. M. (2008) · International Journal of Eating Disorders · doi:10.1002/eat.20522 · Cited by 166
Herpertz, S. C., Zanarini, M. C., Schulz, C. S., Siever, L. J., Lieb, K., Möller, H., & Wfsbp Task Force on Personality Dis (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701685224 · Cited by 166
The Psychopharmacology of Aggressive Behavior
Comai, S., Tau, M., & Gobbi, G. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f8770 · Cited by 132
Schulz, S. C., Zanarini, M. C., BATEMAN, A. W., Bohus, M., Detke, H. C., Trzaskoma, Q., Tanaka, Y., Lin, D., Deberdt, W. G., & Corya, S. A. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037903 · Cited by 126
Gartlehner, G., Crotty, K., Kennedy, S. M., Edlund, M. J., Ali, R., Siddiqui, M., Fortman, R., Wines, R., Persad, E., & Viswanathan, M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00855-4 · Cited by 126
The Psychopharmacology of Aggressive Behavior
Comai, S., Tau, M., Pavlovic, Z. M., & Gobbi, G. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31824929d6 · Cited by 121
Verheul, R., & Herbrink, M. (2007) · International Review of Psychiatry · doi:10.1080/09540260601095399 · Cited by 119
Duggan, C., Huband, N., Smailagic, N., Ferriter, M., & Adams, C. (2007) · Personality and Mental Health · doi:10.1002/pmh.22 · Cited by 112
James, A. C., Taylor, A., Winmill, L., & Alfoadari, K. (2008) · Child and Adolescent Mental Health · doi:10.1111/j.1475-3588.2007.00470.x · Cited by 114
The Essential Nature of Borderline Psychopathology
Zanarini, M. C., & Frankenburg, F. R. (2007) · Journal of Personality Disorders · doi:10.1521/pedi.2007.21.5.518 · Cited by 146
Soler, J., Valdepérez, A., Feliu-Soler, A., Pascual, J. C., Portella, M. J., Martín-Blanco, A., Alvarez, E., & Pérez, V. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.12.002 · Cited by 111
Self-citationPharmacotherapy for Borderline Personality Disorder—Current Evidence and Recent Trends
Stoffers‐Winterling, J., & Lieb, K. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0534-0 · Cited by 119
Linehan, M. M., McDavid, J. D., Brown, M. Z., Sayrs, J. H. R., & Gallop, R. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0617 · Cited by 113
Pharmacological interventions for people with borderline personality disorder
Stoffers‐Winterling, J., Storebø, O. J., Ribeiro, J. P., Kongerslev, M., Vӧllm, B., Mattivi, J. T., Faltinsen, E. G., Todorovac, A., Jørgensen, M. S., Edemann-Callesen, H., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956.pub2 · Cited by 128
Psychotic symptoms in patients with borderline personality disorder
Schroeder, K., Fisher, H. L., & Schäfer, I. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835a2ae7 · Cited by 110
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2013) · Cited by 93
Pennay, A. E., Cameron, J., Reichert, T., Strickland, H., Lee, N., Hall, K., & Lubman, D. I. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.05.004 · Cited by 93
Dixon, L. J., & Linardon, J. (2020) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2019.1620324 · Cited by 86
Evidence-based pharmacotherapy for personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000071 · Cited by 83
Nos, M., Cipriani, A., Biancosino, B., Grassi, L. G., & Barbui, C. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000224784.90911.66 · Cited by 82
Patients with Borderline Personality Disorder in Emergency Departments
Shaikh, U., Qamar, I., Jafry, F., Hassan, M., Shagufta, S., Odhejo, Y. I., & Ahmed, S. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00136 · Cited by 74
Paris, J. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153457 · Cited by 73
Alcohol Use Disorder and Antisocial and Borderline Personality Disorders
Helle, A. C. (2019) · Alcohol research · doi:10.35946/arcr.v40.1.05 · Cited by 84
Zanarini, M. C., Conkey, L. C., Temes, C. M., & Fitzmaurice, G. M. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11153 · Cited by 71
[Validation of a Spanish version of the Diagnostic Interview for Bordelines-Revised (DIB-R)].
Barrachina, J., Soler, J., Campins, M. J., Tejero, A., Pascual, J. C., Álvarez, E., Zanarini, M. C., & Pérez, V. (2004) · PubMed · Cited by 70
Self-citationAggression in Borderline Personality Disorder
Látalová, K., & Praško, J. P. (2010) · Psychiatric Quarterly · doi:10.1007/s11126-010-9133-3 · Cited by 75
Long-Term Course of Borderline Personality Disorder: A Prospective 10-Year Follow-Up Study
Álvarez, I., Soler, J., Bados, A., Martín‐Blanco, A., Elices, M., Carmona, C., Bauzà, J., & Pascual, J. C. (2016) · Journal of Personality Disorders · doi:10.1521/pedi_2016_30_269 · Cited by 70
Self-citationMaffei, C., Cavicchioli, M., Movalli, M., Cavallaro, R., & Fossati, A. (2018) · Substance Use & Misuse · doi:10.1080/10826084.2018.1480035 · Cited by 76
Santamarina‐Perez, P., Mendez, I., Singh, M. K., Berk, M., Picado, M., Font, E., Moreno, E., Martínez, E., Morer, A., Borràs, R., et al. (2020) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12612 · Cited by 67
Efficacy of Quetiapine for Impulsivity and Affective Symptoms in Borderline Personality Disorder
den Eynde, F. V., Şentürk, V., Naudts, K. H., Vogels, C., Bernagie, K., Thas, O., Heeringen, C. V., & Audenaert, K. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166c4bf · Cited by 66
Jones, L. J., & Norton, W. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.055 · Cited by 68
Bellino, S., Rinaldi, C., & Bogetto, F. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500203 · Cited by 64
Clinical Trials of Treatment for Personality Disorders
Paris, J. (2008) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.03.013 · Cited by 57
Efficacy and Tolerability of Pharmacotherapies for Borderline Personality Disorder
Bellino, S., Paradiso, E., & Bogetto, F. (2008) · CNS Drugs · doi:10.2165/00023210-200822080-00005 · Cited by 60
Vita, A., Peri, L. M. D., & Sacchetti, E. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822c1636 · Cited by 59
Abraham, P. F., & Calabrese, J. R. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.024 · Cited by 57
Feliu‐Soler, A., Pascual, J. C., Borràs, X., Portella, M. J., Martín‐Blanco, A., Armario, A., Álvarez, E., Pérez, V., & Soler, J. (2013) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.1837 · Cited by 57
Self-citationPsychopharmacologic treatment of borderline personality disorder
Ripoll, L. H. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.2/lripoll · Cited by 54
Stogios, N., Smith, E., Bowden, S., Tran, V., Asgariroozbehani, R., McIntyre, W. B., Remington, G. J., Siskind, D. J., Agarwal, S. M., & Hahn, M. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01163-7 · Cited by 57
Differential Effectiveness of Antipsychotics in Borderline Personality Disorder
Ingenhoven, T., & Duivenvoorden, H. J. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182217a69 · Cited by 53
Pascual, J. C., Córcoles, D., Castano, J., Gines, J. M., Gurrea, A., Martín‐Santos, R., García-Ribera, C., Pérez, V., & Bulbena, A. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.9.1199 · Cited by 53
Self-citationBozzatello, P., Rocca, P., Rosa, M. L. D., & Bellino, S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1686482 · Cited by 51
Pascual, J. C., Martín‐Blanco, A., Soler, J., Ferrer, A., Tiana, T., Álvarez, E., & Pérez, V. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833e23ed · Cited by 49
Self-citationKohrt, B. A., Maharjan, S. M., Timsina, D., & Griffith, J. L. (2012) · Annals of Anthropological Practice · doi:10.1111/j.2153-9588.2012.01094.x · Cited by 46
Kolla, N. J., Eisenberg, H., & Links, P. S. (2008) · Archives of Suicide Research · doi:10.1080/13811110701542010 · Cited by 45
Bellino, S., Bozzatello, P., Rinaldi, C., & Bogetto, F. (2011) · Depression Research and Treatment · doi:10.1155/2011/680194 · Cited by 45
Bellino, S., Zizza, M., Rinaldi, C., & Bogetto, F. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705201106 · Cited by 45
Belli, H. (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1042w · Cited by 45
Duggan, C. F., Huband, N., Smailagic, N., Ferriter, M., & Adams, C. E. (2008) · Personality and Mental Health · doi:10.1002/pmh.41 · Cited by 44
Stages of change in dialectical behaviour therapy for borderline personality disorder
Soler, J., Trujols, J., Pascual, J. C., Portella, M. J., Barrachina, J., Campins, J., Tejedor, R., Álvarez, E., & Pérez, V. (2008) · British Journal of Clinical Psychology · doi:10.1348/014466508x314882 · Cited by 43
Self-citationMethodological Considerations for Treatment Trials for Persons with Borderline Personality Disorder
Zanarini, M. C., Stanley, B., Black, D. W., Markowitz, J. C., Goodman, M. S., Pilkonis, P. A., Lynch, T. R., Levy, K. N., Fonagy, P., Bohus, M., et al. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200202 · Cited by 42
Borderline Personality Disorder and Depression: An Update
Luca, M., Luca, A., & Calandra, C. (2011) · Psychiatric Quarterly · doi:10.1007/s11126-011-9198-7 · Cited by 40
Rohde, C., Polcwiartek, C., Correll, C. U., & Nielsen, J. (2017) · Journal of Personality Disorders · doi:10.1521/pedi_2017_31_328 · Cited by 39
Tratamento farmacológico da impulsividade e do comportamento agressivo
do Prado‐Lima, P. A. S. (2009) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462009000600004 · Cited by 39
Attachment Theory and Multiple Integrated Treatments of Borderline Patients
Liotti, G., Cortina, M., & Farina, B. (2008) · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry · doi:10.1521/jaap.2008.36.2.295 · Cited by 40
Ciesinski, N. K., Sorgi, K. M., Cheung, J. C., Chen, E. Y., & McCloskey, M. S. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104122 · Cited by 49
Psychopathologie und Therapie der Borderline-Persönlichkeitsstörung
Bohus, M., & Schmahl, C. G. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2341-x · Cited by 37
Impulsivity and its Therapeutic Management in Borderline Personality Disorder: a Systematic Review
Mungo, A., Hein, M., Hubain, P., Loas, G., & Fontaine, P. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-020-09845-z · Cited by 38
Personality Trait Dimensions and the Pharmacological Treatment of Borderline Personality Disorder
Saunders, E. F. H., & Silk, K. R. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181b2b9f3 · Cited by 35
Clinical psychopharmacology of borderline personality disorder
Ripoll, L. H. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834c3f19 · Cited by 33
Bozzatello, P., Rocca, P., Uscinska, M., & Bellino, S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0458-4 · Cited by 32
Gianoli, M. O., Jane, J. S., O’Brien, E. M., & Ralevski, E. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0027999 · Cited by 27
Scheifes, A., Stolker, J. J., Egberts, T. C. G., Nijman, H. L. I., & Heerdink, E. R. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01353.x · Cited by 28
Pharmacotherapy of Borderline Personality Disorder: A Systematic Review
Bellino, S., Rinaldi, C., Bozzatello, P., & Bogetto, F. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796504682 · Cited by 26
Pharmacological treatments for personality disorders
Paris, J. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.586993 · Cited by 25
Damsa, C., Adam, É., Gregorio, F. D., Cailhol, L., Lejeune, J., Lazignac, C., & Allen, M. H. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.10.012 · Cited by 25
Current Clinical Psychopharmacology in Borderline Personality Disorder
CASALE, A. D., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210610092958 · Cited by 30
Pharmacotherapy of personality disorders
Triebwasser, J., & Siever, L. J. (2007) · Journal of Mental Health · doi:10.1080/09638230601182078 · Cited by 23
Off-label use of atypical antipsychotics in personality disorders
Rosenbluth, M. J., & Sinyor, M. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.608351 · Cited by 24
Moen, R., Freitag, M., Miller, M., Lee, S., Romine, A., Song, S., Adityanjee, A., & Schulz, S. C. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400402 · Cited by 21
Impulsivity in bipolar and substance use disorders
Özten, M., Erol, A., Karayilan, S., Kapudan, H., Orsel, E. S., & Kumsar, N. A. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.02.013 · Cited by 21
Wieland, J., van den Brink, A., & Zitman, F. G. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1025836 · Cited by 21
Wasser, T., Tyler, R., McIlhaney, K., Taplin, R., & Henderson, L. (2008) · Best practices in mental health · doi:10.70256/923691pxodmt · Cited by 21
The Black Book of Psychotropic Dosing and Monitoring
DeBattista, C., & Schatzberg, A. F. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4493 · Cited by 23
Impulsivity differences between bipolar and unipolar depression
Özten, M., & Erol, A. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_166_18 · Cited by 20
Salami, T. K., Brooks, B. A., & Lamis, D. A. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120505196 · Cited by 21
Kushner, K., & Marnocha, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012088520-6.50010-x · Cited by 19
Bellino, S., Paradiso, E., & Bogetto, F. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.006 · Cited by 18
Özdemir, P. G., Selvı, Y., & Aydın, A. (2012) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20120418 · Cited by 18
Borderline personality disorder: current drug treatments and future prospects
Olabi, B., & Hall, J. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310368455 · Cited by 19
Borderline Personality Disorder
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.249 · Cited by 14
Williams, S. E., Hartstone, M. D., & Denson, L. A. (2010) · Behaviour Change · doi:10.1375/bech.27.4.251 · Cited by 15
Haro, M. V. N., Guillén, V., Badenes‐Ribera, L., Borao, L., & García‐Palacios, A. (2020) · Cognitive Therapy and Research · doi:10.1007/s10608-020-10170-9 · Cited by 15
Lungu, A., & Linehan, M. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803457-6.00018-0 · Cited by 13
Psychopharmacologic Management of Suicidality in Personality Disorders
Cardish, R. J. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/07067437070526s110 · Cited by 12
Bozzatello, P., & Bellino, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.578910 · Cited by 7
Francois, D., Roth, S. D., & Klingman, D. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150803-09 · Cited by 11
Díaz‐Marsá, M., Galian, M. E., Montes, A., Fernández, R., Arza, R., López-Ibor, J. J., & Carrasco, J. L. (2008) · Actas Españolas de Psiquiatría · Cited by 11
Intervenciones psicológicas eficaces para el tratamiento del trastorno límite de la personalidad
Yust, C. C., Gustavo, Á., Pérez-Díaz, L., & de Salud, S. A. (2012) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 10
Medications in the treatment of borderline personality disorder 2006
Mercer, D. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0010-1 · Cited by 10
Treatment Advances in Borderline Personality Disorder
Nelson, K. J., & Schulz, S. C. (2012) · Psychiatric Annals · doi:10.3928/00485713-20120124-06 · Cited by 9
Marraccini, M. E., Brick, L. A. D., Weyandt, L. L., Francis, A. R., Clarkin, C. M., & Fang, Y. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.01.041 · Cited by 9
Metadata
- Authors
- Soler, J., Pascual, J. C., Campins, J., Barrachina, J., Puigdemont, D., Alvarez, E., & Pérez, V.
- Affiliations
- Hospital de Sant Pau (ES)
- Venue
- American Journal of Psychiatry
- Published
- 2005-06-01
- Volume
- 162
- Issue
- 6
- Pages
- 1221-1224
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2149470409
- Cited by
- 224
- References
- 6
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 10 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 4 · 2019: 11 · 2018: 2 · 2017: 12 · 2016: 9 · 2015: 6 · 2014: 13 · 2013: 10 · 2012: 18
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- borderline personality disorder, dialectical behavior therapy, olanzapine, combined psychotherapy and pharmacotherapy, depression, anxiety, impulsivity, aggression, treatment discontinuation
- MeSH terms
- Olanzapine, Adult, Behavior Therapy, Benzodiazepines, Borderline Personality Disorder, Combined Modality Therapy, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Placebos, Antipsychotic Agents, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review